Anti-angiogenic effect of tetraacetyl-phytosphingosine

Experimental Dermatology

Volumn 16, Issue 4, 2007, Pages 311-317

  Kwon, Yoo Bin ^a   Kim, Chang Deok ^a   Kim, Bo Joong ^a   Kim, Min Young ^b   Park, Chang Seo ^c,d   Yoon, Tae Jin ^e   Seo, Young Joon ^a   Suhr, Ki Beom ^a   Park, Jang Kyu ^a   Lee, Jeung Hoon ^a  

^a Chungnam National University   (South Korea)

^b AngioLab Inc   (South Korea)

^c Korea Advanced Institute of Science & Technology   (South Korea)

^d Dongguk University   (South Korea)

^e Gyeongsang National University School of Medicine   (South Korea)

Author keywords

Angiogenesis; Calcium; Mitogen activated protein kinase; Proteolytic enzyme; Tetraacetyl phytosphingosine

Indexed keywords

CALCIUM; GELATINASE A; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHYTOSPHINGOSINE; PLASMINOGEN ACTIVATOR INHIBITOR 1; STRESS ACTIVATED PROTEIN KINASE; TETRAACETYLPHYTOSPHINGOSINE; UNCLASSIFIED DRUG; UROKINASE; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; CALCIUM CELL LEVEL; CELL MIGRATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; LASER MICROSCOPY; NONHUMAN; PROTEIN DEGRADATION; RABBIT; UMBILICAL VEIN; WOUND HEALING;

ACETYLATION; ANIMALS; CALCIUM; CELL MOVEMENT; CELLS, CULTURED; ENDOTHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MATRIX METALLOPROTEINASE 2; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHORYLATION; PLASMINOGEN ACTIVATOR INHIBITOR 1; RABBITS; SIGNAL TRANSDUCTION; SPHINGOSINE; UMBILICAL VEINS; URINARY PLASMINOGEN ACTIVATOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 33947151010     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2006.00530.x     Document Type: Article

References (41)

1. Liscovitch M, Cantley L C. Lipid second messengers. Cell 1994: 77: 329-334.
2. Maceyka M, Payne S G, Milstien S, Spiegel S. Sphingosine kinase, sphingosine-1-phosphate, and apoptosis. Biochim Biophys Acta 2002: 1585: 193-201.
3. 2+ mobilization by sphingosylphosphorylcholine and galactosylsphingosine in HL60 leukemia cells. Implications of GTP-binding protein-coupled receptors for lysosphingolipids. J Biol Chem 1995: 270: 26332-26340.
4. Seufferlein T, Rozengurt E. Sphingosylphosphorylcholine activation of mitogen-activated protein kinase in Swiss 3T3 cells requires protein kinase C and a pertussis toxin-sensitive G protein. J Biol Chem 1995: 270: 24334-24342.
5. 2+-dependent pathway. Am J Physiol 1998: 275: C1255-C1263.
6. Xu Y, Zhu K, Hong G et.al. Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1. Nat Cell Biol 2000: 2: 261-267.
7. Payne S G, Milstien S, Spiegel S. Sphingosine-1-phosphate: Dual messenger functions. FEBS Lett 2002: 531: 54-57.
8. Anliker B, Chun J. Cell surface receptors in lysophospholipid signaling. Semin Cell Dev Biol 2004: 15: 457-465.
9. Spiegel S, Milstien S. Sphingolipid metabolites: Members of a new class of lipid second messengers. J Membr Biol 1995: 146: 225-237.
10. Zanglis A, Lianos E A, Demopoulos C A. The biological activity of acetylated sphingosylphosphorylcholine derivatives. Int J Biochem Cell Biol 1996: 28: 63-74.
11. Higuchi K, Kawashima M, Takagi Y et.al. Sphingosylphosphorylcholine is an activator of transglutaminase activity in human keratinocytes. J Lipid Res 2001: 42: 1562-1570.
12. Boguslawski G, Grogg J R, Welch Z et.al. Migration of vascular smooth muscle cells induced by sphingosine 1-phosphate and related lipids: potential role in the angiogenic response. Exp Cell Res 2002: 274: 264-274.
13. Piao Y J, Lee C H, Zhu M J et.al. Involvement of urokinase-type plasminogen activator in sphingosylphosphorylcholine-induced angiogenesis. Exp Dermatol 2005: 14: 356-362.
14. Kye K C, Chae E K, Piao Y J et.al. Signaling events during induction of plasminogen activator inhibitor-1 expression by sphingosylphosphorylcholine in cultured human dermal fibroblasts. J Invest Dermatol 2004: 122: 1365-1371.
15. Wickerham L J, Stodola F H. Formation of extracellular sphingolipides by microorganisms. I. Tetraacetylphytosphingosine from Hansenula ciferri. J Bacteriol 1960: 80: 484-491.
16. Kim H J, Kim H J, Kim S H, Kim T Y. Tetraacetyl phytosphingosine-induced caspase activation and apoptosis occur through G2 arrest in human keratinocyte HaCaT cells. J Invest Dermatol 2003: 121: 1135-1137.
17. Kim H J, Shin W, Park C S, Kim H O, Kim T Y. Differential regulation of cyclooxygenase-2 expression by phytosphingosine derivatives, NAPS and TAPS, and its role in the NAPS or TAPS-mediated apoptosis. J Invest Dermatol 2003: 121: 1126-1134.
18. Sun L, Xu L, Henry F A, Spiegel S, Nielsen T B. A new wound healing agent-sphingosylphosphorylcholine. J Invest Dermatol 1996: 106: 232-237.
19. Prager G W, Breuss J M, Steurer S, Mihaly J, Binder B R. Vascular endothelial growth factor (VEGF) induces rapid prourokinase (pro-uPA) activation on the surface of endothelial cells. Blood 2004: 103: 955-962.
20. Yan L, Borregaard N, Kjeldsen L, Moses M A. The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. J Biol Chem 2001: 276: 37258-37265.
21. McGrath M H, Emery J M. The effect of inhibition of angiogenesis in granulation tissue on wound healing and the fibroblast. Ann Plast Surg 1985: 15: 105-122.
22. Lee P C, Salyapongse A N, Bragdon G A et.al. Impaired wound healing and angiogenesis in eNOS-deficient mice. Am J Physiol 1999: 277: H1600-H1608.
23. Pepper M S. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol 2001: 21: 1104-1117.
24. Irigoyen J P, Munoz-Canoves P, Montero L, Koziczak M, Nagamine Y. The plasminogen activator system: Biology and regulation. Cell Mol Life Sci 1999: 56: 104-132.
25. Yao J S, Chen Y, Zhai W, Xu K, Young W L, Yang G Y. Minocycline exerts multiple inhibitory effects on vascular endothelial growth factor-induced smooth muscle cell migration: The role of ERK1/2, PI3K, and matrix metalloproteinases. Circ Res 2004: 95: 364-371.
26. Wu Y, Zhang Q, Ann D K et.al. Increased vascular endothelial growth factor may account for elevated level of plasminogen activator inhibitor-1 via activating ERK1/2 in keloid fibroblasts. Am J Physiol Cell Physiol 2004: 286: C905-C912.
27. Faehling M, Kroll J, Fohr K J et.al. Essential role of calcium in vascular endothelial growth factor A - induced signaling: Mechanism of the antiangiogenic effect of carboxyamidotriazole. FASEB J 2002: 16: 1805-1807.
28. Polverini P J. The pathophysiology of angiogenesis. Crit Rev Oral Biol Med 1995: 6: 230-247.
29. Arbiser J L. Angiogenesis and the skin: A primer. J Am Acad Dermatol 1996: 34: 486-497.
30. Longo R, Sarmiento R, Fanelli M, Capaccetti B, Gattuso D, Gasparini G. Anti-angiogenic therapy: Rationale, challenges and clinical studies. Angiogenesis 2002: 5: 237-256.
31. Boguslawski G, Lyons D, Harvey K A, Kovala A T, English D. Sphingosylphosphorylcholine induces endothelial cell migration and morphogenesis. Biochem Biophys Res Commun 2000: 272: 603-609.
32. Osborne N, Stainier D Y. Lipid receptors in cardiovascular development. Annu Rev Physiol 2003: 65: 23-43.
33. McVerry B J, Garcia J G. In vitro and in vivo modulation of vascular barrier integrity by sphingosine 1-phosphate: Mechanistic insights. Cell Signal 2005: 17: 131-139.
34. Sottile J. Regulation of angiogenesis by extracellular matrix. Biochim Biophys Acta 2004: 1654: 13-22.
35. Pepper M S, Ferrara N, Orci L, Montesano R. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun 1991: 181: 902-906.
36. Olofsson B, Korpelainen E, Pepper M S et.al. Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells. Proc Natl Acad Sci USA 1998: 95: 11709-11714.
37. 2+ in VEGF- and FGF-induced choroidal endothelial cell proliferation. Am J Physiol Cell Physiol 2001: 281: C1448-C1456.
38. Zhou H, Summers S A, Birnbaum M J, Pittman R N. Inhibition of Akt kinase by cell-permeable ceramide and its implications for ceramide-induced apoptosis. J Biol Chem 1998: 273: 16568-16575.
39. Lee O H, Kim Y M, Lee Y M et.al. Sphingosine 1-phosphate induces angiogenesis: Its angiogenic action and signaling mechanism in human umbilical vein endothelial cells. Biochem Biophys Res Commun 1999: 264: 743-750.
40. Yabu T, Tomimoto H, Taguchi Y, Yamaoka S, Igarashi Y, Okazaki T. Thalidomide-induced antiangiogenic action is mediated by ceramide through depletion of VEGF receptors, and is antagonized by sphingosine-1-phosphate. Blood 2005: 106: 125-134.
41. Park M T, Choi J A, Kim M J et.al. Suppression of extracellular signal-related kinase and activation of p38 MAPK are two critical events leading to caspase-8- and mitochondria-mediated cell death in phytosphingosine-treated human cancer cells. J Biol Chem 2003: 278: 50624-50634.